Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value
$351.51M
Total Bought
$0
Total Sold
$32.34M
Net Transaction
-$32.34M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
COMPASS THERAPEUTICS INC(CMPX)7,788,1507,788,150041,82241,19911.72%-623
SIONNA THERAPEUTICS INC(SION)2,478,0302,478,0300101,94699,34428.26%-2,602
CAMP4 THERAPEUTICS CORP(CAMP)3,035,8252,190,920-844,90518,6109,6622.75%-8,948
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)2,626,9462,626,946032,88923,5116.69%-9,378
IMMUNOME INC(IMNM)4,768,5833,613,799-1,154,784102,42979,03422.48%-23,395
UPSTREAM BIO INC(UPB)2,459,7032,459,703066,78122,1376.30%-44,644
ZENAS BIOPHARMA INC(ZBIO)3,919,1593,919,1590142,30576,62021.80%-65,685
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q1 2026 | TickerTrail